Vext Science, Inc.
VEXTF
$0.1058
-$0.0007-0.66%
| Weiss Ratings | VEXTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | D | |||
| Rating Factors | VEXTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | VEXTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.41 | |||
| Price History | VEXTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.94% | |||
| 30-Day Total Return | -9.96% | |||
| 60-Day Total Return | -26.53% | |||
| 90-Day Total Return | -22.83% | |||
| Year to Date Total Return | -18.62% | |||
| 1-Year Total Return | -39.54% | |||
| 2-Year Total Return | -44.32% | |||
| 3-Year Total Return | -74.20% | |||
| 5-Year Total Return | -79.20% | |||
| 52-Week High % Change | -60.81% | |||
| 52-Week Low % Change | 21.05% | |||
| Price | VEXTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.27 | |||
| 52-Week Low Price | $0.09 | |||
| 52-Week Low Price (Date) | Dec 16, 2024 | |||
| 52-Week High Price (Date) | May 13, 2024 | |||
| Valuation | VEXTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 25.80M | |||
| Enterprise Value | 61.00M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.03 | |||
| Earnings Per Share Growth | -185.71% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.77 | |||
| Price/Book (Q) | 0.31 | |||
| Enterprise Value/Revenue (TTM) | 1.78 | |||
| Price | $0.11 | |||
| Enterprise Value/EBITDA (TTM) | -35.80 | |||
| Enterprise Value/EBIT | -3.83 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | VEXTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 248.66M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | VEXTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 4152 N. 39th Ave. Phoenix, AZ 85019 | |||
| Website | www.vextscience.com | |||
| Country | United States | |||
| Year Founded | 2015 | |||
| Profitability | VEXTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -46.59% | |||
| Profit Margin | -22.18% | |||
| Management Effectiveness | VEXTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -7.62% | |||
| Return on Equity | -- | |||
| Income Statement | VEXTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 34.22M | |||
| Total Revenue (TTM) | 34.22M | |||
| Revenue Per Share | $0.14 | |||
| Gross Profit (TTM) | 8.72M | |||
| EBITDA (TTM) | -1.70M | |||
| EBIT (TTM) | -15.94M | |||
| Net Income (TTM) | -7.59M | |||
| Net Income Avl. to Common (TTM) | -7.59M | |||
| Total Revenue Growth (Q YOY) | 10.96% | |||
| Earnings Growth (Q YOY) | -35.83% | |||
| EPS Diluted (TTM) | -0.03 | |||
| EPS Diluted Growth (Q YOY) | 17.07% | |||
| Balance Sheet | VEXTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.84M | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 28.50M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 84.90M | |||
| Current Ratio (Q) | 1.649 | |||
| Book Value Per Share (Q) | $0.35 | |||
| Total Assets (Q) | 143.46M | |||
| Total Current Liabilities (Q) | 17.29M | |||
| Total Debt (Q) | 40.33M | |||
| Total Liabilities (Q) | 58.56M | |||
| Total Common Equity (Q) | 84.90M | |||
| Cash Flow | VEXTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -6.45M | |||
| Cash from Financing (TTM) | 5.78M | |||
| Net Change in Cash (TTM) | -780.10K | |||
| Levered Free Cash Flow (TTM) | 14.55M | |||
| Cash from Operations (TTM) | -110.90K | |||
